In this review, we have demonstrated that the intra-tumoral expression of MACC1 facilitates cancer immune evasion through multiple processes (Figure 1, Table 1), all leading toward the altered expression of immune system-controlling surface molecules or cytokines, ultimately inducing changes in the composition and function of the TME. The gene discussed is MACC1; the disease is cancer.